应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
ZY Zymergen, Inc.
停牌 10-18 16:00:00 EDT
2.43
+0.00
0.00%
最高
2.43
最低
2.43
成交量
0.00
今开
2.43
昨收
2.43
日振幅
0.00%
总市值
2.54亿
流通市值
1.35亿
总股本
1.04亿
成交额
572.63万
换手率
0.00%
流通股本
5,538万
市净率
1.07
ROE
-90.55%
每股收益
-3.54
52周最高
11.87
52周最低
1.10
市盈率
-0.69
股息
0.00
股息收益率
0.00
ROA
-27.91%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
亚宝药业(600351.SH)：ZY-A001获得药物临床试验批准通知书
智通财经 · 02-14
亚宝药业(600351.SH)：ZY-A001获得药物临床试验批准通知书
合成生物巨头，为什么一个个倒下了?
美股研究社 · 2024-08-28
合成生物巨头，为什么一个个倒下了?
加载失败，点击重试
公司概况
公司名称：
Zymergen, Inc.
所属市场：
NASDAQ
上市日期：
2021-04-22
主营业务：
Zymergen Inc.于2013年在特拉华州注册成立。他们与Nature合作，设计，开发和商业化基于生物的突破性产品，这些产品将为广泛行业的客户提供非凡的价值。他们的首批创新产品包括专为电子公司设计的，可用于新型智能设备（包括可卷起的平板电脑）和天然紫外线防护产品的薄膜。
发行价格：
31.00
{"stockData":{"symbol":"ZY","market":"US","secType":"STK","nameCN":"Zymergen, Inc.","latestPrice":2.43,"timestamp":1666123200000,"preClose":2.43,"halted":3,"volume":0,"delay":0,"floatShares":55375154,"shares":104355336,"eps":-3.5414,"marketStatus":"停牌","change":0,"latestTime":"10-18 16:00:00 EDT","open":2.43,"high":2.43,"low":2.43,"amount":5726327.805341,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.5414,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746604800000},"marketStatusCode":5,"adr":0,"listingDate":1619064000000,"exchange":"NASDAQ","adjPreClose":2.43,"volumeRatio":0},"requestUrl":"/m/hq/s/ZY/tweets","defaultTab":"tweets","newsList":[{"id":"2511658132","title":"亚宝药业(600351.SH)：ZY-A001获得药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2511658132","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511658132?lang=zh_cn&edition=full","pubTime":"2025-02-14 15:33","pubTimestamp":1739518394,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亚宝药业(600351.SH)发布公告，近日，公司收到了国家药品监督管理局核准签发的ZY-A001的《药物临床试验批准通知书》(通知书编号：2025LP00369)，在进一步完善临床试验方案的基础上，同意本品开展用于儿童急性上呼吸道感染的确证性临床试验。ZY-A001的适应症为清热解毒，镇静安神，主要用于儿童急性上呼吸道感染的治疗。截至公告披露日，公司ZY-A001项目已投入研发费用约340.52万元人民币。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1249868.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK0077","BK4539","600351","BK0096","BK1583","BK0239","BK4090","BK0201","BK1576","03347","BK0028","ZY"],"gpt_icon":0},{"id":"2462451351","title":"合成生物巨头，为什么一个个倒下了?","url":"https://stock-news.laohu8.com/highlight/detail?id=2462451351","media":"美股研究社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462451351?lang=zh_cn&edition=full","pubTime":"2024-08-28 19:26","pubTimestamp":1724844360,"startTime":"0","endTime":"0","summary":"关于合成生物，有个重要却反直觉的趋势。另一方面，被视为合成生物灯塔的三只美股，近两年却迅速而惨烈的跌倒。首先是Amyris在去年宣布破产，今年更是接连出售数个化妆品和个护品牌。例如专注于医药产品的美国合成生物公司已经产生了强大的影响，微生物生产的蛋白质治疗药物和“生物制剂”已经占美国新批准药物的四分之一。初创公司 Pivot Bio 设计了两种土壤微生物菌株，并宣布已拿下了约 3%的美国市场。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2024-08-28/doc-incmfcme1693147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01477","BK1191","ZY","BK1574","BK4090","BK4539"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zymergen.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.023},{"period":"1month","weight":0.1152},{"period":"3month","weight":-0.0636},{"period":"6month","weight":-0.0466},{"period":"1year","weight":0.1021},{"period":"ytd","weight":-0.0385}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Zymergen Inc.于2013年在特拉华州注册成立。他们与Nature合作，设计，开发和商业化基于生物的突破性产品，这些产品将为广泛行业的客户提供非凡的价值。他们的首批创新产品包括专为电子公司设计的，可用于新型智能设备（包括可卷起的平板电脑）和天然紫外线防护产品的薄膜。","exchange":"NASDAQ","name":"Zymergen, Inc.","nameEN":"Zymergen, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Zymergen, Inc.(ZY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Zymergen, Inc.(ZY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Zymergen, Inc.,ZY,Zymergen, Inc.股票,Zymergen, Inc.股票老虎,Zymergen, Inc.股票老虎国际,Zymergen, Inc.行情,Zymergen, Inc.股票行情,Zymergen, Inc.股价,Zymergen, Inc.股市,Zymergen, Inc.股票价格,Zymergen, Inc.股票交易,Zymergen, Inc.股票购买,Zymergen, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Zymergen, Inc.(ZY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Zymergen, Inc.(ZY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}